MAIA Biotechnology, Inc. (MAIA)
XASE:MAIA
Total Valuation
MAIA Biotechnology, Inc. has a market cap or net worth of $75.23M. The enterprise value is -$8.61B.
Market Cap$75.23M
Enterprise Value-$8.61B
Share Statistics
MAIA Biotechnology, Inc. has 60,671,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding60,671,490
Owned by Insiders12.99%
Owned by Institutions1.76%
Financial Efficiency
MAIA Biotechnology, Inc.’s return on equity (ROE) is -9.43 and return on invested capital (ROIC) is -627.41%.
Return on Equity (ROE)-9.43
Return on Assets (ROA)-2.31
Return on Invested Capital (ROIC)-627.41%
Return on Capital Employed (ROCE)-6.27
Revenue Per Employee0.00
Profits Per Employee-1.72B
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MAIA Biotechnology, Inc. is ―. MAIA Biotechnology, Inc.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio0.00
PB Ratio20.68
Price to Fair Value20.68
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio0.07
Income Statement
In the last 12 months, MAIA Biotechnology, Inc. had revenue of 0.00 and earned -22.40M in profits. Earnings per share was -0.70.
Revenue0.00
Gross Profit0.00
Operating Income-24.27M
Pretax Income-22.40M
Net Income-22.40M
EBITDA-24.27M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -18.84B and capital expenditures 0.00, giving a free cash flow of -18.84B billion.
Operating Cash Flow-18.84B
Free Cash Flow-18.84B
Free Cash Flow per Share-310.60
Dividends & Yields
MAIA Biotechnology, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.49
52-Week Price Change-15.07%
50-Day Moving Average1.78
200-Day Moving Average1.59
Relative Strength Index (RSI)34.23
Average Volume (3m)570.23K
Important Dates
MAIA Biotechnology, Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MAIA Biotechnology, Inc. as a current ratio of 1.66, with Debt / Equity ratio of 0.00%
Current Ratio1.66
Quick Ratio1.66
Debt to Market Cap0.00
Net Debt to EBITDA356.74
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MAIA Biotechnology, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MAIA Biotechnology, Inc. EV to EBITDA ratio is 354.72, with an EV/FCF ratio of 0.46.
EV to Sales0.00
EV to EBITDA354.72
EV to Free Cash Flow0.46
EV to Operating Cash Flow0.46
Balance Sheet
MAIA Biotechnology, Inc. has $8.66B in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.66B billion.
Cash & Marketable Securities$8.66B
Total Debt$0.00
Net Cash$8.66B
Net Cash Per Share$142.70
Tangible Book Value Per Share$0.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MAIA Biotechnology, Inc. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside704.60% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast44.50%